Pharmena S.A. (PHR.WA)
PLN 4.0
(-3.15%)
PLN 4.0
(-3.15%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 33.03 Million | 1.81 Million | -3.22 Million | -2.24 Million | -13.14 Million | 3.61 Million |
| Net Income | 32.92 Million | -1.41 Million | -4.45 Million | -6.27 Million | -10.67 Million | -190 Thousand |
| Depreciation & Amortization | 325 Thousand | 561 Thousand | 626 Thousand | 628 Thousand | 643 Thousand | 321 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 2.34 Million | 2.09 Million | 465 Thousand | 2.94 Million | -3.2 Million | 3.05 Million |
| Other non-cash items | -2.56 Million | 571 Thousand | 141 Thousand | 453 Thousand | 99 Thousand | 429 Thousand |
| Investing Cash Flow | -3.13 Million | -219 Thousand | -248 Thousand | -198 Thousand | -273 Thousand | -446 Thousand |
| Investments in PPE | -314 Thousand | -226 Thousand | -319 Thousand | -214 Thousand | -273 Thousand | -446 Thousand |
| Acquisitions | -3.26 Million | 12 Thousand | 71 Thousand | 16 Thousand | - | - |
| Investment purchases | -62 Thousand | -4000.00 | - | - | - | - |
| Sales/Maturities of investments | 20 Thousand | -12 Thousand | - | - | - | - |
| Other Investing Activities | 493 Thousand | 11 Thousand | 71 Thousand | 16 Thousand | - | - |
| Financing Cash Flow | -9.26 Million | -1.46 Million | 3.21 Million | 3.11 Million | 13.99 Million | -2.91 Million |
| Debt repayment | -8.56 Million | -370 Thousand | -10 Thousand | -1 Million | -6.5 Million | -3.57 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 1.5 Million | 12.59 Million | 33 Thousand |
| Other Financing Activities | -696 Thousand | -1.09 Million | 3.22 Million | 2.6 Million | 7.9 Million | 627 Thousand |
| Accounts receivables | 4.47 Million | -503 Thousand | -682 Thousand | 610 Thousand | -1.4 Million | 2.49 Million |
| Accounts payables | -9.33 Million | 503 Thousand | 612 Thousand | 2.48 Million | -462 Thousand | -36 Thousand |
| Inventory | 4.11 Million | -1.1 Million | 535 Thousand | -148 Thousand | -1.34 Million | 597 Thousand |
| Other working capital | 3.08 Million | 3.2 Million | 6000.00 | -4000.00 | -5000.00 | 2.45 Million |
| Cash at beginning of period | 1.59 Million | 1.46 Million | 1.72 Million | 1.04 Million | 469 Thousand | 221 Thousand |
| Cash at end of period | 22.23 Million | 1.59 Million | 1.46 Million | 1.72 Million | 1.04 Million | 469 Thousand |
| Capital Expenditure | -314 Thousand | -226 Thousand | -319 Thousand | -214 Thousand | -273 Thousand | -446 Thousand |
| Effect of forex changes on cash | 6000.00 | -2000.00 | -3000.00 | -6000.00 | - | - |
| Net cash flow / Change in cash | 20.64 Million | 132 Thousand | -262 Thousand | 674 Thousand | 579 Thousand | 248 Thousand |
| Free Cash Flow | 32.71 Million | 1.59 Million | -3.54 Million | -2.45 Million | -13.41 Million | 3.16 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -904 Thousand | 235 Thousand | -481 Thousand | 32.92 Million | 36.03 Million | -2.55 Million |
| Depreciation & Amortization | 24 Thousand | 29 Thousand | 34 Thousand | 325 Thousand | 26 Thousand | 133 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 129 Thousand | -664 Thousand | 620 Thousand | 2.34 Million | -44.09 Million | 45.12 Million |
| Other non-cash items | 361 Thousand | -325 Thousand | -426 Thousand | -2.56 Million | -4.31 Million | 2.11 Million |
| Investing Cash Flow | -64 Thousand | -2000.00 | 228 Thousand | -3.13 Million | 121 Thousand | -3.4 Million |
| Investments in PPE | -45 Thousand | -2000.00 | -95 Thousand | -314 Thousand | 14 Thousand | -131 Thousand |
| Acquisitions | -19 Thousand | - | 3.26 Million | -3.26 Million | - | - |
| Investment purchases | - | - | -62 Thousand | -62 Thousand | - | - |
| Sales/Maturities of investments | - | - | 20 Thousand | 20 Thousand | - | - |
| Other Investing Activities | 131 Thousand | 468 Thousand | -2.9 Million | 493 Thousand | 107 Thousand | -3.26 Million |
| Financing Cash Flow | -9.47 Million | -18 Thousand | -12 Thousand | -9.26 Million | -5.75 Million | -2.67 Million |
| Debt repayment | -4000.00 | -1000.00 | -1000.00 | -8.56 Million | -5.63 Million | -2.66 Million |
| Dividends payments | -9.46 Million | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -13 Thousand | -3000.00 | -12 Thousand | -696 Thousand | -120 Thousand | -2000.00 |
| Accounts receivables | 323 Thousand | -187 Thousand | 3.45 Million | 4.47 Million | - | -271 Thousand |
| Accounts payables | -173 Thousand | -464 Thousand | -5.78 Million | -9.33 Million | - | 271 Thousand |
| Inventory | -21 Thousand | -13 Thousand | -129 Thousand | 4.11 Million | 5.23 Million | -161 Thousand |
| Other working capital | -173 Thousand | -464 Thousand | 3.08 Million | 3.08 Million | -49.32 Million | 45.29 Million |
| Cash at beginning of period | 20.77 Million | 22.23 Million | 22.26 Million | 1.59 Million | 40.25 Million | 1.49 Million |
| Cash at end of period | 10.92 Million | 20.77 Million | 22.23 Million | 22.23 Million | 22.26 Million | 40.25 Million |
| Capital Expenditure | -45 Thousand | -2000.00 | -95 Thousand | -314 Thousand | 14 Thousand | -131 Thousand |
| Effect of forex changes on cash | - | - | 5000.00 | 6000.00 | -4000.00 | 5000.00 |
| Net cash flow / Change in cash | -9.84 Million | -1.46 Million | -32 Thousand | 20.64 Million | -17.98 Million | 38.76 Million |
| Free Cash Flow | -354 Thousand | -1.44 Million | -348 Thousand | 32.71 Million | -12.33 Million | 44.69 Million |
TRU
1643
688683
WDO
9704
KDSX